Possible involvement of metformin in downregulation of neuroinflammation and associated behavioural changes in mice

No abstract is available for this paper.

• Publication year

  2019

• Venue

  InflammoPharmacology

• Publication date

  2019-09-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10787-019-00638-wPMID 31482259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice

  2019cited by this paper
• Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling Pathway

  2018cited by this paper
• AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages

  2018cited by this paper
• AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.

  2017cited by this paper
• Transporters Involved in Metformin Pharmacokinetics and Treatment Response.

  2017cited by this paper
• AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System

  2017cited by this paper
• The blood-brain barrier in systemic inflammation.

  2017cited by this paper
• Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats

  2017cited by this paper
• Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature

  2017cited by this paper
• Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice.

  2016cited by this paper
• Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice.

  2016cited by this paper
• Neuropharmacological Actions of Metformin in Stroke

  2015cited by this paper
• Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance.

  2015cited by this paper
• Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion

  2014cited by this paper
• Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture

  2014cited by this paper
• Metabolism of inflammation limited by AMPK and pseudo-starvation

  2013cited by this paper
• Propolis and its constituent caffeic acid suppress LPS-stimulated pro-inflammatory response by blocking NF-κB and MAPK activation in macrophages.

  2013cited by this paper
• Impact of caffeic acid on aluminium chloride‐induced dementia in rats

  2013cited by this paper
• Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS‐induced inflammatory responses via TLR4‐mediated NF‐κB inactivation in RAW 264.7 macrophages

  2012cited by this paper
• Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation

  2012cited by this paper
• Prolonged Depression-Like Behavior Caused by Immune Challenge: Influence of Mouse Strain and Social Environment

  2011cited by this paper
• Immune system to brain signaling: neuropsychopharmacological implications.

  2011cited by this paper
• Review: Role of metformin in the management of polycystic ovary syndrome

  2010cited by this paper
• Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-κB and JNK activations in microglia cells.

  2010cited by this paper
• Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways.

  2009cited by this paper
• Cytokine, sickness behavior, and depression.

  2009cited by this paper
• Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice

  2009cited by this paper
• Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells

  2006cited by this paper
• Blood-brain barrier transport of cytokines: a mechanism for neuropathology.

  2005cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?

  2000cited by this paper
• Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice.

  2000cited by this paper
• Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli.

  1999cited by this paper
• Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.

  1998cited by this paper
• THE USE OF KNOCKOUT MICE TO UNDERSTAND THE ROLE OF CYTOKINES IN FEVER

  1998cited by this paper
• Effects of fetal alcohol exposure on fever, sickness behavior, and pituitary-adrenal activation induced by interleukin-1 beta in young adult rats.

  1996cited by this paper
• Clinical Pharmacokinetics of Metformin

  1996cited by this paper
• Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice.

  1994cited by this paper
• Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury.

  1990cited by this paper

• Metformin Improves Spatial Memory and Reduces Seizure Severity in a Rat Model of Epilepsy and Alzheimer’s Disease comorbidity via PI3K/Akt Signaling Pathway

  2025cites this paper
• Natural Antioxidants Reduce Oxidative Stress and the Toxic Effects of RNA-CUG(exp) in an Inducible Glial Myotonic Dystrophy Type 1 Cell Model

  2025cites this paper
• Impact of Prior Metformin Use on Stroke Outcomes: A Systematic Review and Updated Meta-Analysis

  2025cites this paper
• The potential of metformin in weight loss

  2025cites this paper
• AMPK: an enzyme that may be effective in cancer and metabolic diseases

  2025cites this paper
• Effect of Metformin on Clinical Course of Non-Diabetic Patients with Ischemic Stroke

  2025cites this paper
• Neuroprotective Roles of Metformin in a Streptozotocin-Induced Dementia Model in Rats

  2025cites this paper
• Age-dependent neuroinflammation response to voluntary wheel running and Metformin treatment in the frontal cortex of ovariectomized female mice

  2025cites this paper
• Metformin Reduces Viability and Inhibits the Immunoinflammatory Profile of Human Glioblastoma Multiforme Cells

  2024cites this paper
• Safeguarding the brain from oxidative damage.

  2024cites this paper
• Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice

  2024influential citation
• The Impact of Pre-Stroke Metformin Use on Clinical Outcomes after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective

  2023cites this paper
• Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis

  2023cites this paper
• Metformin role in Parkinson’s disease: a double-sword effect

  2023cites this paper
• Effect of D‐pinitol on MK‐801‐induced schizophrenia‐like behaviors in mice

  2023influential citation
• Portulaca oleracea L. (purslane) improves the anti-inflammatory, antioxidant and autophagic actions of metformin in the hippocampus of diabetic demented rats.

  2023cites this paper
• A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices

  2023cites this paper
• Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour

  2023cites this paper
• Involvement of NLRP3 inflammasome pathway in the protective mechanisms of ferulic acid and p-coumaric acid in LPS-induced sickness behavior and neuroinflammation in mice

  2023cites this paper
• Metformin improves neurobehavioral impairments of streptozotocin‐treated and western diet‐fed mice: Beyond glucose‐lowering effects

  2022cites this paper
• Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications

  2022cites this paper
• Diabetes, antidiabetic medications and risk of depression - A population-based cohort and nested case-control study.

  2022cites this paper
• An overview of the neurological aspects in COVID-19 infection

  2022cites this paper
• Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes

  2022cites this paper
• Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice

  2022cites this paper
• Dose-dependent immunomodulatory effects of metformin on human neonatal monocyte-derived macrophages.

  2022cites this paper
• Mechanism of metformin regulation in central nervous system: Progression and future perspectives.

  2022cites this paper
• Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride.

  2021cites this paper
• Qiangji Decoction Alleviates Neurodegenerative Changes and Hippocampal Neuron Apoptosis Induced by D-Galactose via Regulating AMPK/SIRT1/NF-κB Signaling Pathway

  2021cites this paper
• In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease

  2021cites this paper
• Possible involvement of agmatine in neuropharmacological actions of metformin in diabetic mice.

  2021cites this paper
• Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder

  2021cites this paper
• Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF

  2021cites this paper
• Metformin: A Novel Weapon Against Inflammation

  2021cites this paper
• NRF2 as a Therapeutic Target in Neurodegenerative Diseases

  2020cites this paper
• Effect of coffee constituents, caffeine and caffeic acid on anxiety and lipopolysaccharide-induced sickness behavior in mice

  2020cites this paper
• Inhibition of NLRP3-inflammasome mediated IL-1β release by phenylpropanoic acid derivatives: in-silico and in-vitro approach.

  2020cites this paper
• Metformin Ameliorates Lipopolysaccharide-Induced Depressive-Like Behaviors and Abnormal Glutamatergic Transmission

  2020cites this paper
• Involvement of the nervous system in COVID-19: The bell should toll in the brain

  2020cites this paper
• Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders.

  2020cites this paper
• Effects of metformin on lifespan, cognitive ability and inflammatory response in a short-lived fish.

  2020cites this paper
• Enhanced conditioning of adverse memories in the mouse modified swim test is associated with neuroinflammatory changes - effects that are susceptible to antidepressants.

  2020cites this paper
• Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice

  2019cites this paper